(ALNY) Alnylam Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Alnylam Pharmaceuticals | (ALNY) share price targets
Complete technical analysis of Alnylam Pharmaceuticals (ALNY) by charts plus indicators, forecast predictions and share price targets for Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-09-03 View latest technical analysis
10 day averaged volume of Alnylam Pharmaceuticals is 971790
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Wed Sep 2025 | 447.43 | 444.77 | 456.18 | 442.73 | 1.339 times |
| 02 Tue Sep 2025 | 447.00 | 445.84 | 454.50 | 441.50 | 1.103 times |
| 29 Fri Aug 2025 | 446.51 | 452.22 | 453.96 | 444.79 | 0.852 times |
| 29 Fri Aug 2025 | 446.51 | 452.22 | 453.96 | 444.79 | 0.852 times |
| 28 Thu Aug 2025 | 452.33 | 452.01 | 457.29 | 451.12 | 0.66 times |
| 27 Wed Aug 2025 | 454.18 | 449.05 | 455.45 | 447.63 | 0.933 times |
| 26 Tue Aug 2025 | 451.20 | 451.50 | 451.50 | 444.25 | 1.218 times |
| 25 Mon Aug 2025 | 443.64 | 453.37 | 458.75 | 442.38 | 1.235 times |
| 22 Fri Aug 2025 | 454.38 | 469.17 | 469.81 | 454.20 | 1.107 times |
| 21 Thu Aug 2025 | 467.55 | 459.62 | 467.71 | 454.68 | 0.782 times |
My analysis of stock is bullish for shortterm, and stock might move up till 456.9 or till 468.3. Use a stoploss of 447.37 and if this stock hits its stoploss, then it can fall down till 437.86
Share price targets for Alnylam Pharmaceuticals (ALNY)
| Target Type | Value |
| Downside Target | 245.96 |
| Downside Target | 295.82 |
| Downside Target | 306.00 |
| Downside Target | 327.21 |
| Downside Target | 382.19 |
| Downside Target | 402.43 |
| Downside Target | 421.81 |
| Downside Target | 441.50 |
| Upside Target | 453.96 |
| Upside Target | 456.18 |
| Upside Target | 458.75 |
| Upside Target | 469.81 |
Intraday share price targets for Alnylam Pharmaceuticals (ALNY)
| Target Type | Value |
| Downside Intraday Target | 440.56 |
| Downside Intraday Target | 433.69 |
| Upside Intraday Target | 455.24 |
| Upside Intraday Target | 463.05 |
| Upside Intraday Target | 448.37 |
Weekly technical analysis of Alnylam Pharmaceuticals (ALNY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Wed Sep 2025 | 447.43 | 445.84 | 456.18 | 441.50 | 2.867 times |
| 29 Fri Aug 2025 | 446.51 | 452.22 | 453.96 | 444.79 | 0.174 times |
| 29 Fri Aug 2025 | 446.51 | 453.37 | 458.75 | 442.38 | 0.794 times |
| 22 Fri Aug 2025 | 454.38 | 450.00 | 469.81 | 447.10 | 0.912 times |
| 15 Fri Aug 2025 | 448.91 | 433.65 | 449.52 | 421.81 | 1.302 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Alnylam Pharmaceuticals (ALNY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Wed Sep 2025 | 447.43 | 445.84 | 456.18 | 441.50 | 0.095 times |
| 29 Fri Aug 2025 | 446.51 | 388.68 | 469.81 | 382.19 | 1.076 times |
| 31 Thu Jul 2025 | 392.24 | 324.77 | 402.43 | 309.57 | 1.443 times |
| 30 Mon Jun 2025 | 326.09 | 303.10 | 327.21 | 295.82 | 0.703 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Alnylam Pharmaceuticals (ALNY)
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term but the sell signal is initial and weak.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 450.49 and Alnylam Pharmaceuticals (ALNY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals (ALNY) stock. Volume based technical analysis of Alnylam Pharmaceuticals (ALNY) stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term but the sell signal is initial and weak.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 450.49 and Alnylam Pharmaceuticals (ALNY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals (ALNY) stock. Volume based technical analysis of Alnylam Pharmaceuticals (ALNY) stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.